60 results
6-K
EX-99.2
GLPG
Galapagos NV
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
by the European Commission, Great Britain’s Medicines and Healthcare products Regulatory Agency, and the Japanese
Ministry of Health, Labour and Welfare … we work hand in hand with patients, patient organizations, scientists, healthcare professionals, research institutions, academia, and other partners
6-K
EX-99.1
GLPG
Galapagos NV
29 Mar 24
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
6:14am
joining Gilead, Mr. Dickinson worked at Lazard as global co-head of the healthcare investment banking division. Earlier in his career, he served
6-K
EX-99.1
GLPG
Galapagos NV
6 Feb 24
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
6:00am
healthcare business in Europe.”
Galapagos will receive a €50 million upfront payment, potential sales-based milestone payments totaling €120 million … caregivers and healthcare personnel therapeutic solutions according to the highest standards of quality and safety.
Contact
Media inquiries:
Marieke
6-K
EX-99.1
GLPG
Galapagos NV
4 Jan 24
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma
4:05pm
people's health and quality of life by offering caregivers and healthcare personnel therapeutic solutions according to the highest standards of quality
6-K
EX-99.1
fxmkb3
3 Nov 23
Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023
8:26am
6-K
EX-99.1
882 k76t9ygvsm6
2 Nov 23
Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma
7:15am
6-K
EX-99.2
00qe79y6
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
6-K
EX-99.1
g6ayqpegw4k k1nn
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
6-K
EX-99.1
s0ks8ujg xlqc
15 Jun 23
Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
5:03pm
6-K
EX-99.1
tvz pxjnhp6
23 May 23
Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023
7:30am
6-K
EX-99.1
eondf163
5 May 23
Galapagos announces first quarter 2023 financial results
4:05pm
6-K
EX-99.1
5e4bw6r0z383ylxn
14 Nov 22
Current report (foreign)
6:05am
6-K
EX-99.1
5yuah rroz11haqg
9 Nov 22
Current report (foreign)
4:05pm
6-K
EX-99.1
jdoqx 77n
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.2
emxcgcn0w 77x90004u4
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.1
4ir6 6nlwyefnwp2jqkh
4 Nov 22
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
4:57pm
6-K
EX-99.1
hhd614z y9liq
6 Oct 22
Current report (foreign)
5:11pm
6-K
EX-99.1
cn061o
24 Aug 22
Galapagos to present at upcoming investor conferences
4:48pm
6-K
EX-99.2
fmj6sax0
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm